No headlines found.
No press releases found.
No news found.
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investors Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the securitys recent "resistance level", with consideration for various market conditions.
Innovator Ibd Breakout Opportunities ETF trades on the ARCA stock market under the symbol BOUT.
As of April 25, 2024, BOUT stock price declined to $33.06 with 437 million shares trading.
BOUT has a market cap of $13.22 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BOUT stock traded as high as $38.94 and as low as $27.79.
BOUT has underperformed the market in the last year with a price return of +8.5% while the SPY ETF gained +22.7%. BOUT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.9% and -4.7%, respectively, while the SPY returned +3.2% and -2.9%, respectively.
BOUT support price is $32.95 and resistance is $33.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BOUT stock will trade within this expected range on the day.